BioNexus Gene Lab Corp. (BGLC)
1.19
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
1.16
-0.03
(-2.52%)
Pre-Market: 20:00
BioNexus Gene Lab Gross Profit Margin (Quarterly) : 17.06% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.06% |
| March 31, 2026 | -99.56% |
| December 31, 2025 | -6.70% |
| September 30, 2025 | 14.85% |
| June 30, 2025 | 16.28% |
| March 31, 2025 | 16.07% |
| December 31, 2024 | 11.08% |
| September 30, 2024 | 11.11% |
| June 30, 2024 | 13.60% |
| March 31, 2024 | 15.32% |
| December 31, 2023 | 11.73% |
| September 30, 2023 | 13.03% |
| June 30, 2023 | 12.43% |
| March 31, 2023 | 14.64% |
| December 31, 2022 | 11.07% |
| September 30, 2022 | 10.79% |
| June 30, 2022 | 8.88% |
| Date | Value |
|---|---|
| March 31, 2022 | 10.27% |
| December 31, 2021 | 13.34% |
| September 30, 2021 | 18.61% |
| June 30, 2021 | 13.98% |
| March 31, 2021 | 16.58% |
| December 31, 2020 | 14.75% |
| September 30, 2020 | 16.56% |
| June 30, 2020 | 13.53% |
| March 31, 2020 | 21.01% |
| December 31, 2019 | 23.21% |
| September 30, 2019 | 31.82% |
| June 30, 2019 | 21.30% |
| March 31, 2019 | 33.10% |
| December 31, 2018 | -71.28% |
| September 30, 2018 | 24.45% |
| December 31, 2017 | 70.08% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Intertek Group Plc | -- |
| ALS Ltd. | -- |
| NEXT-ChemX Corp. | -- |
| Capital A Bhd. | 62.78% |
| AECOM | -0.95% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -33.16% |
| Return on Assets | -22.90% |
| Return on Invested Capital | -32.35% |
| Profit Margin (Quarterly) | -376.0% |
| Operating Margin (Quarterly) | -409.4% |
| Return on Net Operating Assets | -62.22% |